| Market Cap | ₹2,563Cr |
| ROE | -7.22% |
| P/E Ratio(TTM) | -22.07 |
| EPS(TTM) | -12.59 |
| P/B Ratio | 2.51 |
| Dividend Yield | 0.07% |
| Industry P/E | 34.63 |
| Book Value | 110.79 |
| Debt to Equity | 0.97 |
| Face Value | 2 |
| Parent Organisation | Indoco Remedies Limited |
| Managing Director | Mr. Sundeep Bambolkar |
| NSE Symbol | INDOCO |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 87.58 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.40 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.46 | ||
| Wockhardt | NA (0.00%) | -139.73 |